Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable ATP-dependent RNA helicase DDX56 is an enzyme of the DEAD-box helicase family characterized by the conserved Asp-Glu-Ala-Asp (DEAD) motif. DDX56 is primarily a nucleolar protein with ATPase-dependent RNA unwinding activity central to ribosome biogenesis, particularly assembly of the large 60S ribosomal subunit. It is involved in the regulation of multiple RNA metabolic processes including transcription, splicing, translation, and RNA degradation, and plays a critical role in maintaining nucleolar integrity. DDX56 is overexpressed in several cancers, where it acts as an oncogene by promoting cell proliferation, invasion, and migration while inhibiting apoptosis. Its regulatory influence extends to stem cell maintenance and innate immunity by interfering with pathways such as FOXO1/p21^Cip1/c-Myc and IRF3 nuclear translocation. Although a promising anti-cancer target, its essential roles in normal biology raise cautions regarding possible broad or stem cell-specific toxicities. Note: DDX21 and DDX56 are closely related but distinct genes; aliases including "DDX21" should be treated with caution, as DDX21 has separate biological and disease roles. Otherwise, DDX56 is a valid therapeutic target and molecular entity.
no mechanism of action described for drugs specifically targeting DDX56, but suppression of DDX56 can affect cell cycle, proliferation, apoptosis, and ribosome assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable ATP-dependent RNA helicase DDX56 (DDX56).